27 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Recommendations for Preventing ... Women with in HIV-AIDS ... test) is not recommended ... Preventing First ... infections #HIVAIDS #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Opportunistic Disease in HIV-AIDS ... Papillomavirus (HPV ... Hepatitis A virus (HAV ... Opportunistic #Infections #OIs ... IDSA #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Opportunistic Disease in HIV-AIDS ... Papillomavirus (HPV ... Hepatitis A virus (HAV ... Opportunistic #Infections #OIs ... IDSA #management #pharmacology
HIV Antiretroviral Medications Cheat Sheet

NRTIs
Integrase Inhibitors
NNRTIs
PIs
Fusion Inhibitors
CCR5 Antagonist
Post Attachment Inhibitor
Combination Pills
NRTI-Sparing
Resistance Mutations Summary - https://hivdb.stanford.edu/ 

By
HIV Antiretroviral ... Inhibitors NNRTIs PIs ... @kbrownmd #HIV ... #AIDS #HAART #Medications ... Classification #Pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... Infections in HIV-AIDS ... Preventing 1st ... to 5 mg/kg/day IV ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Recommendations for Preventing ... Infections in HIV-AIDS ... Preventing Bacterial ... illness usually is ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Trypanosomiasis) in HIV-AIDS ... Preventing Clinical ... of this therapy is ... Note: Treatment is ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... 400 mg) PO or IV ... #Candidiasis #candida ... mucosal #IDSA #Prevention ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Recommendations for Preventing ... Encephalitis in HIV-AIDS ... Encephalitis #IDSA #Prevention ... HIVAIDS #management #pharmacology ... #pharmacology
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
Disease (MCD) in HIV-AIDS ... and uncontrolled HIV ... initiation of ART is ... Liposomal doxorubicin is ... infections #HIVAIDS #pharmacology